Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Synthesizing Semantic Characteristics Lung Nodules Classification Method Based on 3D Convolutional Neural Network.

Bioengineering (Basel, Switzerland)·2023
Same author

Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients.

Scientific reports·2017
Same author

Concurrent agglomeration and straining govern the transport of <sup>14</sup>C-labeled few-layer graphene in saturated porous media.

Water research·2017
Same author

Effects of temperature on graphene oxide deposition and transport in saturated porous media.

Journal of hazardous materials·2017
Same author

Computational Analysis of Intra-Ventricular Flow Pattern Under Partial and Full Support of BJUT-II VAD.

Medical science monitor : international medical journal of experimental and clinical research·2017
Same author

Inflammation is independent of steatosis in a murine model of steatohepatitis.

Hepatology (Baltimore, Md.)·2017

Related Experiment Video

Updated: Jun 26, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Machine learning and multi-omics data reveal driver gene-based molecular subtypes in hepatocellular carcinoma for

Meng Wang1, Xinyue Yan1, Yanan Dong1

  • 1Faculty of Environment and Life of Beijing University of Technology, Beijing, China.

Plos Computational Biology
|May 10, 2024
PubMed
Summary

This study identifies two molecular subtypes of Hepatocellular Carcinoma (HCC) using driver genes, revealing distinct survival outcomes and molecular features. These findings pave the way for targeted therapies for liver cancer.

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.5K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.2K

Related Experiment Videos

Last Updated: Jun 26, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.5K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.2K

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Hepatocellular Carcinoma (HCC) exhibits significant heterogeneity, hindering effective treatment strategies.
  • Molecular subtyping of HCC is essential for developing personalized anti-tumor therapies.
  • The role of driver genes in HCC subtyping remains underexplored.

Purpose of the Study:

  • To leverage driver genes for constructing Hepatocellular Carcinoma subtype models.
  • To elucidate the molecular mechanisms underlying identified HCC subtypes.
  • To develop a robust prognostic model for HCC patient stratification.

Main Methods:

  • Expanded a set of driver genes using computational frameworks based on mutation and dysregulation data.
  • Developed a multi-omics subtype classification algorithm integrating mutation and expression data.
  • Utilized single-cell and multi-omics data for in-depth subtype characterization.

Main Results:

  • Successfully classified Hepatocellular Carcinoma into two distinct subtypes, CLASS A and CLASS B, with significant survival differences.
  • Revealed substantial transcriptomic, mutational, copy number variation, and epigenomic distinctions between subtypes.
  • Developed a 10-gene classification model, identifying TTK as a potential therapeutic target.

Conclusions:

  • Driver gene-based subtyping offers a novel approach to understanding Hepatocellular Carcinoma heterogeneity.
  • The identified subtypes and prognostic model provide crucial insights for HCC pathogenesis and treatment development.
  • TTK emerges as a promising therapeutic target for specific HCC subtypes.